https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Proceedings of the National Academy of Sciences, Volume 122, Issue 33, August 2025. <br/>SignificanceEstrogen receptor alpha (ERα) is a transcription factor that drives breast cancer development, serving as the primary therapeutic target in this disease. Endocrine therapies are designed to inhibit ERα action, but resistance to treatment is …
